Screening for Tuberculosis in Migrants: A Survey by the Global Tuberculosis Network

Antibiotics

Nicola Cocco¹  Dominik Zenner²  Adrián Rendon³  Giovanni Sotgiu⁴  Marcela Muñoz Torrico⁵  Simon Tiberi⁶  Emanuele Pontali⁷  Yang Li⁸  Jeremiah Muhwa Chakaya⁹  Rupak Singla^1,10  Fatma Alyaquobi^1,11  Seif Al-Abri^1,11  Valentina Marchese^1,12  Alberto Matteelli^1,12  Denise Rossato Silva^1,13  Anna Cristina C. Carvalho^1,14  Selene Manga^1,15  Evgeny Belilovskiy^1,16  Sergey Borisov^1,16  Ivan Solovic^1,17  Nguyen Viet Nhung^1,18  Marcos Abdo Arbex^1,19  Susanna R. Esposito^2,20  Lia D’Ambrosio^2,21  Margareth Pretti Dalcolmo^2,22  Anh Tuan Dinh-Xuan^2,23  François-Xavier Blanc^2,24  Rosella Centis^2,25  Giovanni Battista Migliori^2,25  Keertan Dheda^2,26  Jean-Pierre Zellweger^2,27  Luigi Ruffo Codecasa^2,28  Claudia C. Dobler^2,29  José-María García-García^3,30  Justin Denholm^3,31  Martin van den Boom^3,32 

[1] ASST Santi Paolo e Carlo—Medicina Penitenziaria, 21100 Milan, Italy;Centre for Global Public Health, Institute for Population Health Sciences, Queen Mary University, London E1 2AB, UK;Centro de Investigación, Prevención y Tratamiento de Infecciones Respiratorias CIPTIR, University Hospital of Monterrey UANL (Universidad Autonoma de Nuevo Leon), Monterrey 64000, Mexico;Clinical Epidemiology and Medical Statistics Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari, 07100 Sassari, Italy;Clínica de Tuberculosis, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, Mexico City 14080, Mexico;Department of Infection, Royal London Hospital, Barts Health NHS Trust, London E1 1FR, UK;Department of Infectious Diseases, Galliera Hospital, 16128 Genoa, Italy;Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai 200040, China;Department of Medicine, Therapeutics, Dermatology and Psychiatry, Kenyatta University, Nairobi P.O. Box 43844-00100, Kenya;Department of TB & Respiratory Diseases, National Institute of TB & Respiratory Diseases, Sri Aurobindo Marg, New Delhi 110030, India;Directorate General of Disease Surveillance and Control, Ministry of Health, Muscat 100, Oman;Division of Infectious and Tropical Diseases, Spedali Civili University Hospital, 25123 Brescia, Italy;Faculdade de Medicina, Universidade Federal do Rio Grande do Sul, Porto Alegre 90035-903, Brazil;Laboratório de Inovações em Terapias, Ensino e Bioprodutos (LITEB), Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro 21040-360, Brazil;Ministry of Health, Direccion General de Gestion de Riesgos en y Desastres en Salud, Lima 15072, Peru;Moscow Research and Clinical Center for Tuberculosis Control, 107014 Moscow, Russia;National Institute for TB, Vysne Hagy, Catholic University, 05984 Ruzomberok, Slovakia;National Tuberculosis Programme, Hanoi 100000, Vietnam;Nestor Goulart Reis Hospital, Health Secretary São Paulo State, Sao Paulo 14801-320, Brazil;Paediatric Clinic, Department of Medicine and Surgery, University Hospital, University of Parma, 43126 Parma, Italy;Public Health Consulting Group, 6900 Lugano, Switzerland;Reference Center Hélio Fraga, Fundação Oswaldo Cruz (Fiocruz), Ministry of Health, Rio de Janeiro 21040-360, Brazil;Respiratory Physiology Unit, Department of Respiratory Medicine, Cochin Hospital, Université de Paris, 75014 Paris, France;Service de Pneumologie, Centre Hospitalier Universitaire, L’institut du Thorax, F-44093 Nantes, France;Servizio di Epidemiologia, Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri IRCCS, 21049 Tradate, Italy;South African MRC Centre for the Study of Antimicrobial Resistance, University of Cape Town, Cape Town 7701, South Africa;TB Competence Center, Swiss Lung Association, 3030 Berne, Switzerland;TB Reference Centre, Villa Marelli Institute, Niguarda Hospital, 20159 Milan, Italy;The George Institute for Global Health, University of New South Wales, Sydney, NSW 2042, Australia;Tuberculosis Research Programme SEPAR, E-08029 Barcelona, Spain;Victorian Tuberculosis Program, Melbourne Health, Melbourne, VIC 3000, Australia;WHO Regional Office for the Eastern Mediterranean Region, Cairo 11571, Egypt;

关键词: TB;    migration;    COVID-19;    TB infection management;    prevention;    infection control;   

DOI  :  10.3390/antibiotics10111355

来源: DOAJ

【 摘 要 】

Tuberculosis (TB) does not respect borders, and migration confounds global TB control and elimination. Systematic screening of immigrants from TB high burden settings and—to a lesser degree TB infection (TBI)—is recommended in most countries with a low incidence of TB. The aim of the study was to evaluate the views of a diverse group of international health professionals on TB management among migrants. Participants expressed their level of agreement using a six-point Likert scale with different statements in an online survey available in English, French, Mandarin, Spanish, Portuguese and Russian. The survey consisted of eight sections, covering TB and TBI screening and treatment in migrants. A total of 1055 respondents from 80 countries and territories participated between November 2019 and April 2020. The largest professional groups were pulmonologists (16.8%), other clinicians (30.4%), and nurses (11.8%). Participants generally supported infection control and TB surveillance established practices (administrative interventions, personal protection, etc.), while they disagreed on how to diagnose and manage both TB and TBI, particularly on which TBI regimens to use and when patients should be hospitalised. The results of this first knowledge, attitude and practice study on TB screening and treatment in migrants will inform public health policy and educational resources.

【 授权许可】

Unknown